ELI LILLY AND COMPANY Current Liabilities
ELI LILLY AND COMPANY (LLY) had Current Liabilities of $47.74 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $47.74B.
- 2026-03-31: Liabilities, Current $36.63B.
- 2025-12-31: Liabilities, Current $35.23B.
- 2025-09-30: Liabilities, Current $40.14B.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $47.74B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $36.63B 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $35.23B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $40.14B 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $39.02B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $30.07B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $28.38B 10-K · filed 2026-02-12 | $28.38B 10-K · filed 2025-02-19 |
| 2024-09-30 | $24.67B 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $27.12B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $18.60B 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $27.29B 10-K · filed 2025-02-19 | |
| 2023-09-30 | $22.00B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $18.91B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $16.01B 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $17.14B 10-K · filed 2024-02-21 | |
| 2022-09-30 | $15.65B 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $15.62B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $13.39B 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $15.05B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $13.68B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $15.09B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $11.71B 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $12.48B 10-K · filed 2022-02-23 | |
| 2020-09-30 | $11.98B 10-Q · filed 2020-10-28 | |
| 2020-06-30 | $11.99B 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $12.61B 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $11.78B 10-K · filed 2021-02-17 | |
| 2019-09-30 | $10.83B 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $11.86B 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $11.24B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $11.89B 10-K · filed 2020-02-19 | |
| 2018-09-30 | $10.83B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $13.06B 10-Q · filed 2018-07-25 | |
| 2018-03-31 | $11.55B 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $14.54B 8-K · filed 2019-10-24 | |
| 2017-09-30 | $12.67B 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $11.29B 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $10.45B 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $10.99B 10-K · filed 2018-02-20 | |
| 2016-09-30 | $8.27B 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $8.40B 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $7.34B 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $8.23B 10-K · filed 2017-02-21 | |
| 2015-09-30 | $8.30B 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $8.23B 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $8.34B 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $9.74B 10-K · filed 2016-02-19 | $11.21B 10-K · filed 2015-02-19 |
| 2014-09-30 | $7.57B 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $7.42B 10-Q · filed 2014-07-28 | |
| 2014-03-31 | $6.63B 10-Q · filed 2014-04-28 | |
| 2013-12-31 | $8.92B 10-K · filed 2015-02-19 | |
| 2013-09-30 | $8.08B 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $8.41B 10-Q · filed 2013-07-26 | |
| 2013-03-31 | $7.59B 10-Q · filed 2013-04-26 | |
| 2012-12-31 | $8.39B 10-K · filed 2014-02-19 | |
| 2012-09-30 | $6.96B 10-Q · filed 2012-10-26 | |
| 2012-06-30 | $6.61B 10-Q · filed 2012-07-27 | |
| 2012-03-31 | $6.55B 10-Q · filed 2012-04-30 | |
| 2011-12-31 | $8.93B 10-K · filed 2013-02-21 | |
| 2011-09-30 | $8.22B 10-Q · filed 2011-10-28 | |
| 2011-06-30 | $8.62B 10-Q · filed 2011-07-29 | |
| 2011-03-31 | $7.65B 10-Q · filed 2011-04-29 | |
| 2010-12-31 | $6.93B 10-K · filed 2012-02-24 | $7.10B 10-K · filed 2011-02-22 |
| 2010-09-30 | $6.10B 10-Q · filed 2010-10-29 | |
| 2010-06-30 | $6.32B 10-Q/A · filed 2010-08-02 | |
| 2010-03-31 | $5.66B 10-Q · filed 2010-07-30 | |
| 2009-12-31 | $6.57B 10-K · filed 2011-02-22 | |
| 2009-09-30 | $6.07B 10-Q · filed 2009-10-30 | |
| 2009-06-30 | $6.99B 10-Q · filed 2009-07-31 | |
| 2008-12-31 | $13.11B 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |